sb.scorecardresearch
Advertisement

Published 07:21 IST, September 22nd 2020

COVID-19 vaccine: AstraZeneca releases trial blueprint, aims for 50% effectiveness

Amid the COVID-19 pandemic, AstraZeneca has released a blueprint for its COVID-19 vaccine Phase-3 trials where it is aiming for 50% effectiveness

Reported by: Shubham Bose
Follow: Google News Icon
  • share
AstraZeneca releases trial blueprint
null | Image: self
Advertisement

07:21 IST, September 22nd 2020